On June 14, 2022, the U.S. Court of Appeals for the Third Circuit affirmed the dismissal of a securities suit brought by investors in pharmaceutical company, Amarin Corporation, PLC, holding that the investors had failed to...more
7/1/2022
/ Blockchain ,
Board of Directors ,
Class Action ,
Dismissals ,
False Statements ,
Food and Drug Administration (FDA) ,
Government Investigations ,
Misleading Statements ,
Putative Class Actions ,
Rule 10b-5 ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Securities Litigation ,
Securities Violations ,
Shareholder Litigation ,
Subpoenas
On April 19, 2022, Judge James R. Knepp II of the U.S. District Court for the Northern District of Ohio approved consent judgments against biotechnology firm Rising Biosciences, Inc. and its CEO Arthur Hall for violations of...more
5/4/2022
/ Class Action ,
Consent Order ,
Coronavirus/COVID-19 ,
Elon Musk ,
Failure To State A Claim ,
False Statements ,
Marriott ,
Misleading Statements ,
Ponzi Scheme ,
Public Statements ,
Putative Class Actions ,
Restraining Orders ,
Rule 10(b) ,
Rule 10b-5 ,
Securities Exchange Act ,
Securities Violations ,
Tesla
Second Circuit Affirms Dismissal of Securities Fraud Class Action Against Alkermes; Delaware Court of Chancery Allows SPAC Litigation to Proceed; Ex-Theranos CEO Elizabeth Holmes Convicted on Four Counts of Fraud; Second...more
1/12/2022
/ Breach of Duty ,
Class Action ,
Dismissals ,
False Statements ,
Fiduciary Duty ,
Investors ,
Misleading Statements ,
Putative Class Actions ,
Remand ,
Scienter ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Special Purpose Acquisition Companies (SPACs) ,
Vacated ,
Wire Fraud